Literature DB >> 16844083

Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

Masashi Kohno1, Hitoshi Hasegawa, Atsushi Inoue, Masatake Muraoka, Tatsuhiko Miyazaki, Keizo Oka, Masaki Yasukawa.   

Abstract

An orphan G-protein-coupled receptor, GPR18, was cloned on the basis of degenerate-oligonucleotide PCR analysis of HUT 102 cells using primers designed from the conservative regions of the human chemokine receptor. GPR18 was expressed significantly in lymphoid cell lines, but not in non-lymphoid hematopoietic cell lines. Moreover, the expression of the GPR18 gene was higher in peripheral lymphocyte subsets (CD4(+), CD4(+)CD45RA(+), CD4(+)CD45RO(+), CD8(+), and CD19(+)) than in monocytes and lymphoid cell lines, and was increased after stimulation with phytohemagglutinin. By screening using a lipid library, N-arachidonylglycine (NAGly) induced an increase in intracellular Ca(2+) concentration in GPR18-transfected cells, which was significantly greater than that in mock-transfected cells. NAGly also inhibited forskolin-induced cAMP production in a pertussis toxin-sensitive manner in the GPR18-transfected CHO cells. This is the first study to demonstrate that NAGly is a natural ligand for GPR18.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844083     DOI: 10.1016/j.bbrc.2006.06.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  102 in total

1.  Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules.

Authors:  Dominik P Waluk; Filip Sucharski; Laszlo Sipos; Jerzy Silberring; Mary C Hunt
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

Review 2.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea.

Authors:  Natalia Murataeva; Laura Daily; Xavier Taylor; Amey Dhopeshwarkar; Sherry Shu-Jung Hu; Sally Miller; Douglas McHugh; Olivia Oehler; Shimin Li; Joseph A Bonanno; Ken Mackie; Alex Straiker
Journal:  Cornea       Date:  2019-07       Impact factor: 2.651

Review 5.  The Endocannabinoid System and its Modulation by Phytocannabinoids.

Authors:  Vincenzo Di Marzo; Fabiana Piscitelli
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 6.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

7.  Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.

Authors:  Hong Yin; Alan Chu; Wei Li; Bin Wang; Fabiola Shelton; Francella Otero; Deborah G Nguyen; Jeremy S Caldwell; Yu Alice Chen
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

Review 8.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

9.  Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.

Authors:  Susan Fung; Allison E Cherry; Cong Xu; Nephi Stella
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

10.  The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.

Authors:  Anusha Penumarti; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.